Skip to main content
Clinical Trials/NCT05944328
NCT05944328
Recruiting
Not Applicable

Effectiveness of a Structured Pharmaceutical Review Intervention of Pharmacotherapeutic Plans to Reduce Medication-related Problems in Geriatric Residences: a Quasi-experimental Pragmatic Assay

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina1 site in 1 country862 target enrollmentFebruary 22, 2023
ConditionsPolypharmacy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Polypharmacy
Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Enrollment
862
Locations
1
Primary Endpoint
Drug-related problems
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Background: Patients living in Geriatric Residences (RG) have increased aging, comorbidity, spending on health resources and mortality. High drug use is associated with an increased risk of falls, disability, and death. It is estimated that 20-50% of inappropriate medications are consumed in the elderly.

Hypothesis: A pharmaceutical intervention based on a clinical review of the pharmacotherapeutic plan of patients in RG will be useful in optimizing the prescription in terms of safety, reducing by 10% or more the inappropriate prescriptions.

Objectives: Evaluate the effectiveness of a structured pharmaceutical intervention based on the clinical review of the pharmacotherapeutic plan to improve its adequacy.

Decrease inadequate prescriptions in patients admitted to RG by 10%

Methodology: Pre-post, quasi-experimental intervention study with control group with prospective follow-up of a cohort of patients in RG. The intervention consists of the clinical review of the pharmacotherapeutic plan carried out by the pharmacist and subsequently agreed in the Pharmacotherapeutic Advisory Committee.

Determinations: The study variables will be evaluated at baseline and 3 months post-intervention. The primary variable is number of inappropriate prescriptions.

Statistical analysis: Percentage change will be measured before and after the intervention. Descriptive statistics will be performed for quantitative variables such as qualitative and comparison of means and proportions.

Expected results: Achieve a 10% decrease in inappropriate prescriptions

Applicability and Relevance: This study will expand the collaboration between the Pharmacy and Primary Care physicians, promoting the continuum of care, strengthening the safety culture, and improving prescribing habits.

Registry
clinicaltrials.gov
Start Date
February 22, 2023
End Date
June 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 65 years or older
  • Pharmacological treatment with at least one drug and for a period of more than three months

Exclusion Criteria

  • Individuals who at the time of the pharmaceutical review were in hospital
  • Patients nearing the end of life
  • Patients whose participation was considered by the doctor responsible to be potentially detrimental
  • Patients not covered by the public healthcare or pharmacy system were excluded.

Outcomes

Primary Outcomes

Drug-related problems

Time Frame: Three months

% patients with prm

Polymedication:

Time Frame: Three months

number of polymedicated patients (\>10 drugs)

Secondary Outcomes

  • Sociodemographic variables(Basal)
  • Description and classification of the DRPs detected Description and classification of the DRPs detected(Three months)

Study Sites (1)

Loading locations...

Similar Trials